Home LiteratureArticle Details
PMID: 15161648 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis.

The American journal of pathology ·Vol. 164 ·No. 6 ·2004-06-00 ·Pages 2139-51

Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, Reinmuth N, Bielenberg D, Bucana CD, Klagsbrun M, Ellis LM

Abstract

Neuropilin-1 (NRP-1), a recently identified co-receptor for vascular endothelial growth factor, is expressed by several nongastrointestinal tumor types and enhances prostate cancer angiogenesis and growth in preclinical models. We investigated the expression and regulation of NRP-1 and the effect of NRP-1 overexpression on angiogenesis and growth of human colon adenocarcinoma by immunohistochemistry and in situ hybridization. NRP-1 was expressed in 20 of 20 human colon adenocarcinoma specimens but not in the adjacent nonmalignant colonic mucosa. By reverse transcriptase-polymerase chain reaction analysis, NRP-1 mRNA was expressed in seven of seven colon adenocarcinoma cell lines. Subcutaneous xenografts of stably transfected KM12SM/LM2 human colon cancer cells overexpressing NRP-1 led to increased tumor growth and angiogenesis in nude mice. In in vitro assays, conditioned medium from NRP-1-transfected cell lines led to an increase in endothelial cell migration, but did not affect endothelial cell growth. Epidermal growth factor (EGF) led to induction of NRP-1 in human colon adenocarcinoma cells and selective blockade of the epidermal growth factor receptor (EGFR) decreased constitutive and EGF-induced NRP-1 expression. Blockade of the Erk 1/2 and P38 mitogen-activated protein kinase signaling pathways also led to a decrease in constitutive and EGF-induced NRP-1 expression. These findings demonstrate the ubiquitous expression of NRP-1 in human colon cancer and suggest that NRP-1 may contribute to colon cancer angiogenesis and growth. This study also suggests that EGF and mitogen-activated protein kinase signaling pathways play an important role in NRP-1 regulation in colon cancer cells.

MeSH Terms
Adenocarcinoma/blood supply,pathology Animals Cell Division Cell Line, Tumor Cloning, Molecular Colonic Neoplasms/blood supply,pathology DNA, Complementary/genetics Epidermal Growth Factor/pharmacology Gene Expression Regulation, Neoplastic/genetics Humans In Situ Hybridization Intestinal Mucosa/blood supply,pathology Mice Mice, Nude Mitogen-Activated Protein Kinases/metabolism Neovascularization, Pathologic/pathology Neuropilin-1/analysis,genetics,physiology Phosphorylation Recombinant Proteins/analysis Transfection Transplantation, Heterologous
Chemicals
DNA, Complementary Recombinant Proteins Neuropilin-1 Epidermal Growth Factor Mitogen-Activated Protein Kinases
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Parikh Alexander A
Departments of Surgical Oncology and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA.
Fan Fan
Liu Wen Biao
Ahmad Syed A
Stoeltzing Oliver
Reinmuth Niels
Bielenberg Diane
Bucana Corazon D
Klagsbrun Michael
Ellis Lee M
References (57)
57 references, click to expand
  1. Expression of vascular endothelial growth factor at the human gastric ulcer margin and in cultured gastric fibroblasts: a new angiogenic factor for gastric ulcer healing.
    Biochem Biophys Res Commun. 1997 May 19;234(2):493-8 PMID: 9177300
  2. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer.
    Arch Surg. 1997 May;132(5):541-6 PMID: 9161399
  3. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165.
    J Biol Chem. 1997 Dec 12;272(50):31582-8 PMID: 9395496
  4. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.
    Cell. 1998 Mar 20;92(6):735-45 PMID: 9529250
  5. Preferential activation of the epidermal growth factor receptor in human colon carcinoma liver metastases in nude mice.
    J Histochem Cytochem. 1998 May;46(5):595-602 PMID: 9562568
  6. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells.
    J Biol Chem. 1998 Aug 21;273(34):22128-35 PMID: 9705358
  7. Expression of epidermal growth factor receptor in normal colonic mucosa and in adenocarcinomas of the colon.
    Acta Physiol Hung. 1997-1998;85(2):121-8 PMID: 9706306
  8. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells.
    Clin Cancer Res. 1995 Jan;1(1):19-31 PMID: 9815883
  9. Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis.
    Int J Oncol. 2001 Feb;18(2):221-6 PMID: 11172585
  10. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells.
    Cell Growth Differ. 2001 Mar;12(3):129-35 PMID: 11306513
  11. Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor.
    Am J Physiol Cell Physiol. 2001 Jun;280(6):C1375-86 PMID: 11350732
  12. Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells.
    Br J Cancer. 2001 Jul 20;85(2):273-8 PMID: 11461089
  13. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells.
    Cancer Res. 2001 Aug 1;61(15):5736-40 PMID: 11479209
  14. Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors.
    Br J Cancer. 2001 Aug 17;85(4):584-9 PMID: 11506500
  15. Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis.
    Cancer. 2001 Sep 1;92(5):1138-43 PMID: 11571726
  16. VEGF receptor signal transduction.
    Sci STKE. 2001 Dec 11;2001(112):re21 PMID: 11741095
  17. Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastoma.
    Cancer. 2002 Jan 1;94(1):258-63 PMID: 11815985
  18. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis.
    Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3657-62 PMID: 11891274
  19. EGF receptor ligands.
    Exp Cell Res. 2003 Mar 10;284(1):2-13 PMID: 12648462
  20. Increased expression of the epidermal growth factor receptor on human colon carcinoma cells.
    Arch Surg. 1986 Nov;121(11):1242-7 PMID: 3535739
  21. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.
    Cancer Res. 1988 Jan 1;48(1):137-41 PMID: 2446740
  22. Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines.
    Cancer Lett. 1988 Dec 1;43(1-2):139-43 PMID: 3264518
  23. Epidermal growth factor receptors in colorectal carcinoma.
    Anticancer Res. 1990 May-Jun;10(3):605-11 PMID: 2195985
  24. Growth modulation by epidermal growth factor (EGF) in human colonic carcinoma cells: constitutive expression of the human EGF gene.
    J Cell Physiol. 1991 Aug;148(2):220-7 PMID: 1880151
  25. Proliferation of human colon cancer cells: role of epidermal growth factor and transforming growth factor alpha.
    Int J Cancer. 1992 Dec 2;52(6):978-86 PMID: 1459740
  26. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.
    Mol Biol Cell. 1993 Jan;4(1):121-33 PMID: 7680247
  27. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor content in normal and carcinomatous gastric and colonic tissue.
    Clin Investig. 1993 Nov;71(11):903-7 PMID: 8312682
  28. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.
    Clin Cancer Res. 1996 Oct;2(10):1679-84 PMID: 9816116
  29. Vascular endothelial growth factor (VEGF) and its receptors.
    FASEB J. 1999 Jan;13(1):9-22 PMID: 9872925
  30. Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors.
    Nat Neurosci. 1998 Oct;1(6):487-93 PMID: 10196546
  31. Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progression.
    Int J Cancer. 1999 Jun 11;81(6):845-50 PMID: 10362127
  32. Neuropilin-1 is expressed on bone marrow stromal cells: a novel interaction with hematopoietic cells?
    Blood. 1999 Oct 1;94(7):2301-9 PMID: 10498602
  33. Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells.
    Cancer Res. 1999 Oct 1;59(19):4804-7 PMID: 10519388
  34. Neuropilin is a mediator of angiogenesis.
    Cancer Metastasis Rev. 2000;19(1-2):29-37 PMID: 11191060
  35. Signaling via vascular endothelial growth factor receptors.
    Exp Cell Res. 1999 Nov 25;253(1):117-30 PMID: 10579917
  36. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity.
    Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2573-8 PMID: 10688880
  37. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms.
    Int J Cancer. 2000 Mar 20;89(2):167-71 PMID: 10754495
  38. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients.
    Eur J Cancer. 2000 Apr;36(6):748-53 PMID: 10762747
  39. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications.
    Oncologist. 2000;5 Suppl 1:11-5 PMID: 10804085
  40. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Cancer. 2000 Aug 1;89(3):488-99 PMID: 10931447
  41. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1.
    J Biol Chem. 2000 Sep 1;275(35):26690-5 PMID: 10842181
  42. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Clin Cancer Res. 2000 Sep;6(9):3739-47 PMID: 10999768
  43. Expression and regulation of neuropilin-1 in human astrocytomas.
    Int J Cancer. 2000 Nov 15;88(4):584-92 PMID: 11058875
  44. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression.
    FASEB J. 2000 Dec;14(15):2532-9 PMID: 11099472
  45. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.
    J Invest Dermatol. 2000 Dec;115(6):1000-7 PMID: 11121133
  46. Molecular biology of the VEGF and the VEGF receptor family.
    Semin Thromb Hemost. 2000;26(5):561-9 PMID: 11129413
  47. Identification of EGF as an angiogenic factor present in conditioned medium from human salivary gland adenocarcinoma cell clones with varying degrees of metastatic potential.
    Cancer Lett. 1994 Sep 15;84(2):189-98 PMID: 8076376
  48. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.
    J Clin Invest. 1995 Apr;95(4):1789-97 PMID: 7535799
  49. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.
    Cancer Res. 1995 Sep 15;55(18):3964-8 PMID: 7664263
  50. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect.
    J Cell Physiol. 1995 Nov;165(2):239-45 PMID: 7593201
  51. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.
    Biol Reprod. 1995 Sep;53(3):636-46 PMID: 7578688
  52. Angiogenesis in cancer, vascular, rheumatoid and other disease.
    Nat Med. 1995 Jan;1(1):27-31 PMID: 7584949
  53. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs.
    Development. 1995 Dec;121(12):4309-18 PMID: 8575331
  54. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
    J Biol Chem. 1996 Mar 8;271(10):5761-7 PMID: 8621443
  55. Growth-associated expression of a membrane protein, neuropilin, in Xenopus optic nerve fibers.
    Dev Neurosci. 1995;17(5-6):343-9 PMID: 8829923
  56. Vascular endothelial growth factor.
    Eur J Cancer. 1996 Dec;32A(14):2413-22 PMID: 9059329
  57. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice.
    Neuron. 1997 Nov;19(5):995-1005 PMID: 9390514
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
2004-06-00
Pages
2139-51
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1615754
Subset
IM
Grants
NCI NIH HHS · CA-16672 · United States
NCI NIH HHS · P30 CA016672 · United States
PHS HHS · 37392 · United States
PHS HHS · 45448 · United States
NCI NIH HHS · CA-09599 · United States
NCI NIH HHS · T32 CA009599 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com